On Friday 26 March 2021, ACI representatives met with the FSA for clarification relating to the novel foods validation process and the publication of the list that they mentioned in their update on 12 March.
Results from a major US trial over 800 people over the past seven months found CBD use has zero impact on the liver. ACI member, Columbia Care, Charlotte’s Web and 10 other US companies provided around $1m for a trial which started last summer – and now appears to have answered the CBD safety question.
ACI member Treehouse Biotech has submitted a Novel Foods application to UK authorities for its Cannabidiol (CBD)-based ingredients in a move that signals the US firm’s intent to capture a slice of the UK’s burgeoning CBD market.
Pharmacy Business Magazine reports that the FSA updated the criteria for CBD products which can remain on sale from 1 April 2021. Previously, only products which were on sale at the time of the FSA’s announcement (13 February 2020) and were linked to an application which had been validated by 31 March 2021 were to be included.
Last February, the Food Standards Agency (FSA) announced that all CBD businesses operating in England and Wales must have a novel foods application “validated” by March 31, 2021, or risk having their CBD oils, drinks, and treats “taken off the shelves.” Now, with just over two weeks left until the deadline, the FSA has clarified that all applications just have to be “submitted” by March 31, 2021.
Coverage from the US publication Hemp Grower on the requirement for novel foods applications to sell CBD products in the UK.
[Cannavist] The Food Standards Agency (FSA) has updated its criteria for CBD products to remain on sale after April 1
Previously, only products that were on sale on February 13, 2020 and linked to an application that had been validated by the March 31, 2021 deadline could continue to be sold.
The criteria for CBD products which can remain on sale from 1 April 2021 has been updated by the Food Standards Agency (FSA).
The FSA has backtracked on its initial expectation for companies to make their novel foods applications at least five weeks in advance of the deadline and confirmed that it will accept applications up until March 31st, after receiving a large number of last minute dossiers.
ACI welcomes the recent update from the UK’s Food Standards Agency concerning the criteria of which CBD products can remain on sale in the UK as of 1st April 2021.